Global Pharmaceutical Companies Show Strong Interest in PS1 as Pharmasaga Advances International Licensing and Co-development Opportunities
- [NEWS] MoneyDJ理財網 : Pharmasaga to List on Emerging Stock Market on 27th; Type 2 Diabetes Phase Ib Clinical Trial Aims for Completion Next Year
- [NEWS] 富聯網 : Unlisted Stocks: Pharmasaga to List on Emerging Stock Market on 27th at NT$120 Reference Price; New Type 2 Diabetes Drug to Announce Phase Ib Data in H1 Next Year
- [NEWS] 富聯網 : (Unlisted Stocks) Pharmasaga to List on Emerging Stock Market on 27th at NT$120, Will Accelerate New Drug Development
- [NEWS] 旺得富 : Pharmasaga to List on Emerging Stock Market on 27th at Reference Price of NT$120
- [NEWS] 旺得富 : (Unlisted Stocks) Pharmasaga to List on Emerging Stock Market on 27th at NT$120, Will Accelerate New Drug Development
- [NEWS] 時報資訊 : (Unlisted Stocks) Pharmasaga to List on Emerging Stock Market on 27th at NT$120, Will Accelerate New Drug Development
- [NEWS] 財訊快報 : Unlisted Stocks: Pharmasaga to List on Emerging Stock Market on 27th at NT$120 Reference Price; New Type 2 Diabetes Drug to Announce Phase Ib Data in H1 Next Year
- [NEWS] GENE ONLINE: Pharmasaga Wins Bronze Medal for Innovative Technology at the 2025 Taipei Biotech Awards
- [NEWS] NTTC: NSTC Leads 8 Biomedical Startups into BIO USA 2025; Pharmasaga Advances to Global Competition Finals Again
- [NEWS] 環球生技 : Pharmasaga's Innovative Diabetes Drug PS1 Demonstrates Curative Potential, Initiates Taiwan-US Clinical Trials
- [NEWS] 經濟部 : BIO 2025 North America Biotech Exhibition Opens; Taiwan Pavilion Showcases Taiwan's Innovative Biomedical Technology
- [NEWS] GENE ONLINE : Taiwan Participates in BIO 2025 North America Biotech Exhibition with Dual Focus on All-Age Healthcare Layout and International Connections
- [NEWS] 環球生技 : NSTC Leads 8 Biomedical Startups to BIO 2025; Pharmasaga Reaches Finals Again
- [NEWS] Yahoo新聞 : Taiwan Pavilion Showcases Taiwan's Biomedical Technology at North America Biotech Exhibition
- [NEWS] Yahoo股市 : BIO 2025 North America Biotech Exhibition: Taiwan Pavilion Highlights 5 Biomedical Innovations
- [NEWS] Ltvnews : Entering BIO USA 2025: NSTC Leads 8 Biomedical Startups; Pharmasaga Advances to Finals Again
- [NEWS] Biomedical Technology Development
- [NEWS] 工商時報 : (Industry) Taiwanese Companies Attend BIO 2025 North America Biotech Exhibition; Ministry of Economic Affairs Reveals 5 Highlights
- [NEWS] CENS : NSTC Leads 8 Biomedical Startups to BIO Exhibition in the US, Aiming for International Licensing and Investment
- [NEWS] GOTHE : Entering BIO USA 2025: NSTC Leads 8 Biomedical Startups; Pharmasaga Advances to Finals Again
US BIO 2026 Day 3 Report
June 24, 2026, Pacific Time
The BIO International Convention 2026 is being held from June 22 to June 25, 2026, in San Diego, California. As one of the largest global events in the biotechnology and life sciences industry, the convention provides an important platform for Pharmasaga to engage with pharmaceutical companies, investors, contract research organizations (CROs),...
Kicking off on June 22nd for four action-packed days, the Pharmasaga team is thrilled to participate once again in the premier global biotech partnering event. We are engaging with leading pharmaceutical companies, investors, and industry partners from around the world to drive our global expansion strategy. 🤝
[Wen-Chin Yang, Founder of Pharmasaga was interviewed on "Silicon Valley Night (SV9) "]
Jun 14
Meeting with McClain
Pharmasaga recently entered into a Confidential Disclosure Agreement (CDA) with McClain, to further explore potential collaboration in the field of drug development.
[California Life Sciences' Spring Innovation Showcase]
[Pharmasaga participate in Bio+Health Track Dinner]
[Pharmasaga participate in SkyDeck x ITRI : Innovation, investment and Global Startup Growth]
[Pharmasaga participate in ITRI : Pitch and Investor Meetup]